CLINICAL_TRIALS
trial_result
· 2018-06-06
Clinical Trial Update: The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis [Phase 2]
Summary
A Phase 2 study evaluating whether increasing dialysate magnesium reduces calcification propensity in patients on haemodialysis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Iain Bressendorff | Conditions: Endstage Renal Disease | Phase 2 | Status: COMPLETED